Sales of breast implants linked to cancer to be suspended in Canada

Canada's health regulator said Thursday that it is advising Allergan that it intends to suspend the licences for Biocell breast implants as a precautionary measure. Health Canada said its move followed the completion of its assessment of textured breast implants as part of a larger ongoing safety review of breast implants. -- More...